Buy Intercept Pharma Stock | ICPT Stock Price & Latest News | Public.com
ICPT

Intercept Pharma

$0.00 (0.00%)Today
    View Intercept Pharma (ICPT) stock trends here

    About ICPT

    Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.67
    -1.34
    -2.02
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.47

    Actual EPS
    Q1 2021

    Stats

    Market Cap$714,78M
    Volume257
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$98.03
    1 Year Low$21.45
    Open$21.66
    High$22.17
    Low$20.65

    Buy any stock with any amount of money.

    Download the App
    Download the app